Last updated on February 2020

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Connective Tissue Diseases | SYSTEMIC LUPUS ERYTHEMATOSUS | Autoimmune disease | Dermatomyositis (Connective Tissue Disease) | CONNECTIVE TISSUE DISEASE
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Have completed the final treatment study visit of an originating study, such as study JAHZ (NCT03616912) or Study JAIA (NCT03616964).

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.